Stress-Protective Effect of Thymic Peptides

Verfasser / Beitragende:
[A. Novoseletskaya, N. Kiseleva, I. Zimina, O. Belova, A. Inozemtsev, V. Arion, V. Sergienko]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 158/6(2015-04-01), 753-755
Format:
Artikel (online)
ID: 605537542
LEADER caa a22 4500
001 605537542
003 CHVBK
005 20210128100858.0
007 cr unu---uuuuu
008 210128e20150401xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-2854-4  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-2854-4 
245 0 0 |a Stress-Protective Effect of Thymic Peptides  |h [Elektronische Daten]  |c [A. Novoseletskaya, N. Kiseleva, I. Zimina, O. Belova, A. Inozemtsev, V. Arion, V. Sergienko] 
520 3 |a Experiments on Wistar rats showed that thymic peptides produce a stress-protective effect that manifested in prevention of functional impairment of conditioned active avoidance response and a decrease in generalized motor activity typical of higher nervous activity failure. We concluded that thymic peptides significantly modulate integrative functions of the brain and produce a stress-protective effect. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a tactivin  |2 nationallicence 
690 7 |a avoidance response  |2 nationallicence 
690 7 |a functional impairment  |2 nationallicence 
690 7 |a stress  |2 nationallicence 
700 1 |a Novoseletskaya  |D A.  |u Department of Higher Nervous Activity, Biological Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia  |4 aut 
700 1 |a Kiseleva  |D N.  |u Department of Pharmacology, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia  |4 aut 
700 1 |a Zimina  |D I.  |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia  |4 aut 
700 1 |a Belova  |D O.  |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia  |4 aut 
700 1 |a Inozemtsev  |D A.  |u Department of Higher Nervous Activity, Biological Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia  |4 aut 
700 1 |a Arion  |D V.  |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia  |4 aut 
700 1 |a Sergienko  |D V.  |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/6(2015-04-01), 753-755  |x 0007-4888  |q 158:6<753  |1 2015  |2 158  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-2854-4  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-2854-4  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Novoseletskaya  |D A.  |u Department of Higher Nervous Activity, Biological Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kiseleva  |D N.  |u Department of Pharmacology, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zimina  |D I.  |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Belova  |D O.  |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Inozemtsev  |D A.  |u Department of Higher Nervous Activity, Biological Faculty, M. V. Lomonosov Moscow State University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Arion  |D V.  |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sergienko  |D V.  |u Laboratory of Molecular Immunology and Biochemistry, Research Institute of Physical-Chemical Medicine, Federal Medical and Biological Agency, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/6(2015-04-01), 753-755  |x 0007-4888  |q 158:6<753  |1 2015  |2 158  |o 10517